Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Xylem Inc. Director's Dealing 2011

Nov 3, 2011

30109_dirs_2011-11-03_147bb367-b3ce-4be4-be0e-69f738b32260.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Xylem Inc. (XYL)
CIK: 0001524472
Period of Report: 2011-11-01

Reporting Person: Wolpert Robert E Jr. (SVP & President, Flow Control)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-11-01 Common Stock A 3516 $0.00 Acquired 8042 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-11-01 Employee Stock Option (Right to Buy) $29.57 A 3243 Acquired 2013-03-06 Common Stock (3243) Direct
2011-11-01 Employee Stock Option (Right to Buy) $32.56 A 3001 Acquired 2014-03-07 Common Stock (3001) Direct
2011-11-01 Employee Stock Option (Right to Buy) $29.81 A 3286 Acquired 2015-03-10 Common Stock (3286) Direct
2011-11-01 Employee Stock Option (Right to Buy) $18.63 A 6127 Acquired 2016-03-05 Common Stock (6127) Direct
2011-11-01 Employee Stock Option (Right to Buy) $30.03 A 7418 Acquired 2020-03-05 Common Stock (7418) Direct
2011-11-01 Employee Stock Option (Right to Buy) $32.38 A 7222 Acquired 2021-03-03 Common Stock (7222) Direct

Footnotes

F1: These options are fully vested and exercisable.

F2: 4,086 options are vested and exercisable and the remainder will vest on March 5, 2012.

F3: 2,474 options are vested and exercisable and the remainder will vest in two equal annual installments beginning on March 5, 2012.

F4: These options vest in three equal annual installments beginning on March 3, 2012.